Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra Silver ETF (AGQ) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

ProShares Ultra Silver ETFTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra Silver ETF vs Neurocrine Biosciences Inc — how do they compare? ProShares Ultra Silver ETF trades at $82.37, while Neurocrine Biosciences Inc trades at $157.95 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, ProShares Ultra Silver ETF nearer its low. Which is the better fit depends on your goals.

AGQNBIX
Sector
Leveraged / InverseHealth
52-Week High
$400.47$185.50
52-Week Low
$49.73$123.10
Market Cap
$16.46B
Enterprise Value
$16.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ProShares Ultra Silver ETF

AGQ is a leveraged ETF that seeks daily investment results corresponding to two times (2x) the daily performance of silver bullion. It is designed for investors seeking magnified short-term exposure to silver prices.

Read more on AGQ

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX